Solving Pharma's Quality Unit Identity Crisis: 483s and Warning Letters Point to Inadequate Quality Oversight.
| Publicado en: | BioPharm International Vol. 33; no. 7; pp. 37 - 38 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Jul2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144535559&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 144535559 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Jul2020 vid: 33 iid: 7 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 144535559 144535559 ppf: 37 ppct: 1 formats: fmt: @attributes: type: P tig: atl: Solving Pharma's Quality Unit Identity Crisis: 483s and Warning Letters Point to Inadequate Quality Oversight. aug: au: Pazhayattil, Ajay sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|